Tenax Therapeutics (TENX) analyst price targets imply 121.4% upside to the current stock level. The article notes that this metric historically hasn’t been reliably predictive, but highlights strong analyst agreement on raising earnings estimates as the key driver behind the implied positive move.
Tenax Therapeutics (TENX) analyst price targets imply 121.4% upside to the current stock level. The article notes that this metric historically hasn’t been reliably predictive, but highlights strong analyst agreement on raising earnings estimates as the key driver behind the implied positive move.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
mildly positive
Sentiment Score
0.15
Ticker Sentiment
